Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
The STEP trial program examining higher-dose semaglutide (2.4 mg weekly) for weight management demonstrated mean weight loss of 12% to 15% over 68 weeks in adults with obesity, significantly exceeding placebo
Instead, choose water, herbal teas, or drinks sweetened with zero-calorie substitutes
This doesnt only apply to microdosing GLP-1s but stopping GLP-1s in general
The company's materials describe this program as involving the same active ingredient associated with branded medications Ozempic and Wegovy
Track Progress: Keep a journal to monitor your weight, blood sugar levels, and any side effects
US$ 21.05
US$ 25.47
US$ 21.25
US$ 25.67
US$ 22.61
US$ 21.01
